Calyxt, Inc. (NASDAQ:CLXT) has been given an average broker rating score of 1.50 (Buy) from the four brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and three have issued a strong buy recommendation on the company.

Analysts have set a 1 year consensus price objective of $26.25 for the company, according to Zacks. Zacks has also given Calyxt an industry rank of 249 out of 265 based on the ratings given to its competitors.

A number of analysts have weighed in on CLXT shares. BMO Capital Markets started coverage on Calyxt in a research report on Monday, October 30th. They issued an “outperform” rating and a $32.00 price target for the company. Zacks Investment Research cut Calyxt from a “hold” rating to a “sell” rating in a research report on Monday, October 16th. Citigroup Inc started coverage on Calyxt in a research report on Tuesday, August 15th. They issued a “buy” rating and a $16.00 price target for the company. Jefferies Group LLC boosted their price objective on Calyxt to $27.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Wells Fargo & Company boosted their price objective on Calyxt from $17.00 to $30.00 and gave the stock an “outperform” rating in a research report on Friday, September 29th.

Calyxt (CLXT) opened at $22.20 on Friday. Calyxt has a 1-year low of $9.26 and a 1-year high of $31.89.

ILLEGAL ACTIVITY WARNING: “Calyxt, Inc. (CLXT) Given Consensus Recommendation of “Buy” by Brokerages” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/04/calyxt-inc-clxt-given-consensus-recommendation-of-buy-by-brokerages.html.

About Calyxt

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

Get a free copy of the Zacks research report on Calyxt (CLXT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Calyxt Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt Inc. and related companies with MarketBeat.com's FREE daily email newsletter.